TGFB1 and pulmonary arterial hypertension: Dysregulated TGF-β signalling accelerates the remodelling of pulmonary vasculature and thus plays a pathogenic role in clinical and preclinical PAH cases (Sharmin et al., 2021; Jia et al., 2023).